Cart
sales@molnova.com
Kuwanon U
CAS No. 123702-95-4
Kuwanon U( —— )
Catalog No. M37866 CAS No. 123702-95-4
Kuwanon U is a strong cholinesterase inhibitor, exhibiting IC 50 values of 19.69 and 10.11 μM, and K i values of 6.48 and 9.59 μM for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1359 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKuwanon U
-
NoteResearch use only, not for human use.
-
Brief DescriptionKuwanon U is a strong cholinesterase inhibitor, exhibiting IC 50 values of 19.69 and 10.11 μM, and K i values of 6.48 and 9.59 μM for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), respectively.
-
DescriptionKuwanon U is a strong cholinesterase inhibitor, exhibiting IC 50 values of 19.69 and 10.11 μM, and K i values of 6.48 and 9.59 μM for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), respectively. Its potential application lies in Alzheimer's disease (AD) research .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123702-95-4
-
Formula Weight438.51
-
Molecular FormulaC26H30O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2C(O[C@@H](C1)C3=CC(C/C=C(/CCC=C(C)C)\C)=C(OC)C=C3O)=CC(O)=CC2O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4-benzyloxycarbonyla...
4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester is a biologically active compound used as an intermediate in the synthesis of a variety of compounds.
-
Parathyroid Hormone ...
pTH (1-44) (human)|Parathyroid Hormone (1-44), human
-
Trans-caffeic acid
Trans-caffeic acid stearyl ester is posited to inhibit melanogenesis signaling while suppressing cAMP levels and, subsequently, MC1R, MITF, tyrosinase, TRP-2 and TRP-1 down-regulation, resulting in the suppression of tyrosinase activity, DOPA oxidase activity and melanin synthesis.
